For the quarter ending 2025-12-31, STE had $104,500K increase in cash & cash equivalents over the period. $199,500K in free cash flow.
| Cash Flow | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
| Net income | 194,400 | 192,400 | 178,000 | 146,075 |
| Depreciation, depletion, and amortization | 122,000 | 121,700 | 119,400 | 122,349 |
| Deferred income taxes | -100 | -100 | 0 | -52,759 |
| Share-based compensation expense | 15,700 | 21,200 | 11,900 | 9,791 |
| Loss on the disposal of property, plant, equipment, and intangibles, net | -3,200 | -100 | 0 | -2,731 |
| Loss on classification as held for sale | - | - | - | 0 |
| Loss (gain) on disposal activities, net | 0 | -300 | 0 | -10,917 |
| Amortization of inventory fair value adjustments | - | - | - | 0 |
| Goodwill, impairment loss | - | - | - | 0 |
| Other items | 1,000 | 1,300 | -14,500 | -3,411 |
| Accounts receivable, net | 15,500 | 5,300 | -119,200 | 108,110 |
| Inventories, net | 1,800 | 18,200 | 42,500 | -73,799 |
| Other current assets | 15,500 | -6,600 | -18,900 | 31,919 |
| Accounts payable | -28,800 | 13,200 | 9,800 | 41,093 |
| Accruals and other, net | 25,600 | -42,900 | -9,200 | 43,403 |
| Net cash provided by operating activities | 298,200 | 287,800 | 420,000 | 260,781 |
| Purchases of property, plant, equipment, and intangibles, net | 98,700 | 86,500 | 93,600 | 70,885 |
| Proceeds from the sale of property, plant, equipment, and intangibles | 10,300 | - | 100 | 9,191 |
| Proceeds from divestiture of businesses | - | - | - | 814,558 |
| Proceeds from sale of other investments | - | - | - | 0 |
| Proceeds from the sale of businesses | 2,911 | 9,806 | -12,717 | - |
| Purchase of investments | 5,000 | 1,800 | - | 10,750 |
| Acquisition of businesses, net of cash acquired | 5,100 | 0 | 15,000 | 480 |
| Net cash (used in) provided by investing activities | -98,500 | -88,300 | -108,500 | -69,800 |
| Repayments of secured debt | - | - | - | 638,125 |
| Payments on private placement senior notes | 80,000 | 0 | 45,000 | - |
| Payments for repurchase of private placement | - | - | - | 80,000 |
| Payments on term loans | 30,000 | 30,000 | -60,000 | - |
| Payments under credit facilities, net | 0 | -4,300 | -30,500 | -127,312 |
| Deferred financing fees and debt issuance costs | 0 | - | - | 0 |
| Acquisition related deferred or contingent consideration | 100 | 100 | 100 | 89 |
| Repurchases of ordinary shares | 50,100 | 100,500 | 10,600 | 263 |
| Cash dividends paid to ordinary shareholders | 61,900 | 61,900 | 56,200 | 56,006 |
| Distributions to noncontrolling interest holders | 1,400 | - | - | 490 |
| Contributions from noncontrolling interest holders | 0 | 0 | 0 | 0 |
| Stock option and other equity transactions, net | 15,400 | 7,600 | 9,300 | 6,089 |
| Net cash used in financing activities | -98,000 | -159,200 | -213,100 | -178,071 |
| Effect of exchange rate changes on cash and cash equivalents | 2,900 | -900 | 9,600 | 3,613 |
| Increase (decrease) in cash and cash equivalents | 104,500 | 39,500 | 108,000 | 16,523 |
| Cash and cash equivalents at beginning of period | 319,200 | 279,700 | 171,700 | 155,178 |
| Cash and cash equivalents at end of period | 423,700 | 319,200 | 279,700 | 171,701 |
STERIS plc (STE)
STERIS plc (STE)